Composition combination containing enriched hill shaddock oil
US-2024325485-A1 · Oct 3, 2024 · US
US10668041B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10668041-B2 |
| Application number | US-201715690520-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 30, 2017 |
| Priority date | Dec 8, 2014 |
| Publication date | Jun 2, 2020 |
| Grant date | Jun 2, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides compositions and methods for treatment of epilepsy in an animal. In one embodiment, a method for treating epilepsy in a companion animal can comprise administering to the companion animal a food composition comprising a medium chain triglyceride (MCT), wherein the MCT is present in the food composition in an effective amount for reducing or preventing seizures when the food composition is administered to the companion animal.
Opening claim text (preview).
What is claimed is: 1. A method for treating epilepsy in a companion animal comprising administering to the companion animal a food composition comprising a medium chain triglyceride (MCT) about 15% to about 50% protein, wherein the MCT is present in the food composition from about 1% to about 7% by weight and is effective for reducing seizures when the food composition is administered to the companion animal, wherein the MCT is of a formula (Formula 1): wherein the R′, R″, and R″′ esterified to the glycerol backbone are each independent fatty acids having 5-12 carbons. 2. The method of claim 1 , wherein the animal is a canine. 3. The method of claim 1 , wherein the animal is a feline. 4. The method of claim 1 , wherein the food composition comprises a nitric oxide releasing compound (NORC). 5. The method of claim 4 , wherein the NORC is arginine. 6. The method of claim 1 , wherein greater than about 95% of the R′, R″, and R″′ are 8 carbons in length. 7. The method of claim 1 , wherein the remaining R′, R″, and R″′ are 6-carbon or 10-carbon fatty acids. 8. The method of claim 1 , further comprising administering an anti-epileptic drug (AED) to the companion animal, wherein the AED is selected from the group consisting of acetazolamide, carbamazepine, chlorazepate, clobazam, clonazepam, diazepam, eslicarbazepine acetate, ethisyxunudem, ethosuximide, felbamate, gabapentin, imepitoin, keppra, lacosamide, lamotrigine, levetiracetam, methylphenobarbitone, nitrazepam, oxcarbazepine, perampanel, piracetam, phenobarbital, phenytoin, potassium bromide, pregabalin, primidone, retigabine, rufinamide, sodium bromide, sodium valproate, stiripentol, sulthiame, tiagabine, topiramate, valporic acid, vigabatrin, zonisamide, salts thereof, derivatives thereof, and mixtures thereof. 9. The method of claim 1 , wherein the food composition is formulated as a pet food composition or a dietary supplement. 10. The method of claim 1 , wherein the food composition further comprises, about 5% to about 40% fat, about 5% to about 10% ash content, and having a moisture content of about 5% to about 20%. 11. The method of claim 1 , wherein the food composition includes an AED, wherein the AED is selected from the group consisting of acetazolamide, carbamazepine, chlorazepate, clobazam, clonazepam, diazepam, eslicarbazepine acetate, ethisyxunudem, ethosuximide, felbamate, gabapentin, imepitoin, keppra, lacosamide, lamotrigine, levetiracetam, methylphenobarbitone, nitrazepam, oxcarbazepine, perampanel, piracetam, phenobarbital, phenytoin, potassium bromide, pregabalin, primidone, retigabine, rufinamide, sodium bromide, sodium valproate, stiripentol, sulthiame, tiagabine, topiramate, valporic acid, vigabatrin, zonisamide, salts thereof, derivatives thereof, and mixtures thereof. 12. The method of claim 1 , wherein the food composition is administered on a regular basis. 13. The method of claim 1 , wherein the food composition is administered on a regular basis for a period of at least one month.
Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital · CPC title
of acids having a carboxyl group bound to a chain of seven or more carbon atoms · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Semi-moist feed · CPC title
Moist feed · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.